In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues

doi:10.1016/J.BJBAS.2016.05.002

Paper

In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues

Published Jun 1, 2016 · M. Ahsan, Yousuf Ansari, Praveen Kumar

Beni-Suef University Journal of Basic and Applied Sciences

Q2 SJR score

5

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

2-(2,4-Dichlorophenoxy)-N-[4-(morpholin-4-yl)phenyl]methylidene-acetohydrazide (8k) shows promising antileishmanial activity with a IC50 of 48.10 M, free from

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues

References

Citations